The US ITC has upheld an import ban on a device sold by Taiwan's APEX found to infringe on ResMed patents, even after a redesign. [ + ]

As part of changes to business support made in the May federal Budget, the Department of Industry's services will be accessed via a new one-stop web portal called the Single Business Service. [ + ]

The National Health and Medical Research Council (NHMRC) is seeking feedback on the document 'Principles for the translation of 'omics'-based tests from discovery to health care'. [ + ]

Calazada's (ASX:CZD) PolyNovo now has approval to market its NovoPore TNP dressing in the majority of its addressable market, after securing approvals in Europe. [ + ]

The Global Innovation Index 2014 has ranked Australia 17th out of 143 economies for having a well-linked innovation ecosystem. [ + ]

Virax Holdings (ASX:VHL) has selected US cancer specialist Dr Joseph Sparano to lead phase I/IIb trials of breast cancer treatment candidate GGTI-2418. [ + ]

Researchers from Harvard University have found that the blisters on bubble wrap can be used as a sheet of small, test-tube-like containers for the analysis of medical and environmental samples. [ + ]

Simultaneously inhibiting the expression of another gene makes targeting telomerase much more effective in suppressing tumour growth. [ + ]

Blocking the malaria parasite's access to proteins needed for its survival may lead to the development of new treatments for this deadly disease. [ + ]

Nominations for The KuDos - Hamilton Science Excellence Awards are now open. The awards were launched in 2007 to celebrate science and innovation from within New Zealand's Waikato region. [ + ]

An international team of scientists has sequenced the genome and characterised the genes of the Asian liver fluke, Opisthorchis viverrini. [ + ]

The NHMRC has launched the Advanced Health Research and Translation Centre initiative. [ + ]

EY's annual report on the global biotechnology industry shows the industry rebounded strongly in 2013, with public companies achieving double-digit revenue growth and a sharp rise in funds raised. Product successes have boosted revenues, drawn investors and motivated large companies to invest strongly in R&D. [ + ]

Calzada (ASX:CZD) plans an organisational restructuring involving appointing a managing director for its PolyNovo business and recruiting new clinical, regulatory, commercial and manufacturing talent. [ + ]

Advanced Cell Diagnostics, a developer of cell- and tissue-based analysis tools, has announced that its RNAscope RNA in situ hybridisation technology has reached two major milestones: the publication of over 100 peer-reviewed papers featuring the technology and an inventory of over 4000 target probes. [ + ]